Pfizer's XELJANZ® (tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing SpondylitisBusiness Wire • 11/18/21
U.S. Inks $5.3 Billion Deal For Pfizer's Antiviral Covid Pill — Growing Its Stockpile Of New Coronavirus TreatmentsForbes • 11/18/21
Pfizer seeks emergency U.S. authorization for 10 million doses of new COVID-19 anti viral drugMarket Watch • 11/18/21
Cardiff Oncology Announces $15 Million Equity Investment from Pfizer through its Pfizer Breakthrough Growth InitiativePRNewsWire • 11/18/21
Pfizer to Provide U.S. Government with 10 Million Treatment Courses of Investigational Oral Antiviral Candidate to Help Combat COVID-19Business Wire • 11/18/21
These 2 Covid pills could be available soon — and they might help end the pandemic. Here's howCNBC • 11/17/21
Imugene Announces Clinical Trial Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate HER-Vaxx in Combination with Avelumab for Treatment of Gastric CancerGlobeNewsWire • 11/17/21
FDA Could Reportedly Sign Off On Pfizer Covid Booster Shots For All Adults This WeekForbes • 11/17/21
Pfizer Seeks Emergency Use Authorization for Novel COVID-19 Oral Antiviral CandidateBusiness Wire • 11/16/21
Pfizer plans to submit FDA application for emergency approval of Covid treatment pill today, CEO saysCNBC • 11/16/21